FaceSay

 

The UAB Institutional Review Board has approved another blinded, randomized controlled trial with high functioning ASD students, ages 3-6, using the current version of FaceSay as the intervention.  Enrollment is expected to reach over 30.

 


Comments




Leave a Reply

Name (required)
Email (not published)
Website


 


Copyright © 2007-2008, Symbionica, LLC, All Rights Reserved